KROS logo

KEROS THERAPEUTICS INC

KROSNASDAQ
🏆 #3023 by market capEarnings Nov 4US Equity
$10.71▲ $0.07 (+0.66%)
Live
1h▲ 0.0%
24h▲ 0.7%
7d▲ 7.3%
14d▲ 7.9%
30d▼ 3.7%
1y▼ 21.9%
🏦Market Cap
$343M
Small Cap
📈Revenue Growth (YoY)
+6775.0%
High Growth
📊Gross Margin
94.7%
High
💵FCF Margin
-322.9%
Thin
⚖️P/S Ratio
22.7x
Expensive
Otter Score
44
Weak
📊

Analyst Ratings

Price
$10.71
Total
17
Raised
0
Lowered
4
Avg PT
$20.33
H / L
$23 / $18
InstitutionActionRatingDate
Leerink Partners
ReiteratedOutperform2026-08-04
Wells Fargo
ReiteratedOverweight2026-08-04
B of A Securities
ReiteratedNeutral2025-11-28
Oppenheimer
ReiteratedOutperform2025-11-12
Wedbush
ReiteratedNeutral2025-11-06
HC Wainwright & Co.
ReiteratedBuy2025-08-08
Scotiabank
ReiteratedSector Outperform2025-05-12
Truist Securities
ReiteratedBuy2025-04-09
Cantor Fitzgerald
DowngradedOverweight → Neutral2025-01-21
Piper Sandler
ReiteratedOverweight2025-01-17
Guggenheim
ReiteratedNeutral2025-01-17
William Blair
DowngradedOutperform → Market Perform2024-12-12
TD Cowen
DowngradedBuy → Hold2024-12-12
BTIG
DowngradedBuy → Neutral2024-12-12
Cowen & Co.
ReiteratedOutperform2023-02-14
SVB Leerink
ReiteratedOutperform2020-12-08
Jefferies
ReiteratedBuy2020-05-04
One row per institution, most recent rating